the two derivatives were administered according to the same time schedule and their doses were chosen on the basis of the clinically adopted ratio , doxorubicin : 4'-epidoxorubicin : 4'-deoxy-doxorubicin = 1:1:0.5 .
C0014582
4
C0013089
doxorubicin